<i>Helicobacter pylori</i> Infection: A 40-Year Journey through Shifting the Paradigm to Transforming the Management

Abstract

<b><i>Background:</i></b> <i>Helicobacter pylori</i> (<i>H. pylori</i>) was discovered 40 years ago and has set a milestone in human medicine. The discovery led to rejection of the dogma of the acidic stomach as a sterile organ and requested to rewrite the chapters on gastric pathophysiology and gastroduodenal diseases. <b><i>Summary:</i></b> Over a period of 40 years following the discovery, more than 50,000 articles can be retrieved in PubMed as of today and illustrate the amount and the intensity of research around the role of this bacterium. <i>H. pylori</i> emerged as cause of chronic gastritis and principal cause of peptic ulcer disease (PUD). Eradication of <i>H. pylori</i> became standard of care in management in PUD. The importance of this was highlighted in 2005 with the Nobel Prize in Medicine awarded to Barry Marshall and Robin Warren. <i>H. pylori</i> became eventually recognized for its oncogenic potential in the stomach and as the main risk factor for gastric cancer development. <b><i>Key Messages:</i></b> <i>H. pylori</i> gastritis is defined as infectious disease and requires therapy in all infected individuals. Strategies of gastric cancer prevention and development of therapies to overcome the increasing antibiotic resistance are main targets in clinical research of today.